Company: LNAI
Filing Date: 2025-02-19
Form Type: 10-K/A
Source: 0001731122-25-000252
Chunk: 9

Company: Lunai Bioworks Inc.
Filing Date: 2025-02-19
Form: 10-K/A
Chunk 9
---
 more robust
immune response to viruses and other difficult to treat infections.

<div align='center'>4</div>

Renovaro Cube Overview

Renovaro Cube is an AI-driven healthcare
technology company focusing on the earliest possible detection of cancer and its recurrence. Renovaro Cube has developed a proprietary
AI platform that analyzes genetics using Explainable AI (as defined below) to provide earlier and more accurate cancer diagnosis. This
platform uses a multi-omics approach to search for individual biomarkers that are present even in asymptomatic patients. This approach
is combined with differential molecular capabilities that are designed to identify, differentiate and pinpoint the exact source. Renovaro
Cube’s process also involves the mining of biomarker panels, which are integrated into a machine learning library referred to as
“RenovaroCube” to further enhance diagnosis.

Renovaro Cube also aims to utilize
its proprietary AI platform in the development of commercial products to support clinical, research and pharmaceutical organizations that
are trying to improve patient care through precision diagnosis, prediction of success of therapy, new drug discovery, treatment protocols
or clinical trials. Specifically, Renovaro Cube is focused on developing products and services aimed at (i) early cancer characterization,
(ii) personalized treatment selection, (iii) prediction and tracking response to therapies, (iv) recurrence detection and efficacy monitoring,
and (v) ultimately, drug discovery.

Renovaro Cube was initially incorporated as Grace Systems B.V. (“Grace Systems”)
in 2013 under the laws of the Netherlands to develop unique data mining algorithms to enable banking, finance and government entities
to extract business insights from data. Grace Systems began applying its algorithms to biological data in 2018 to uncover cancer-associated
patterns. Beginning in 2018, Grace Systems pivoted its platform to focus only on healthcare. Renovaro Cube has focused on developing its
AI technology for early cancer detection.

Renovaro Cube has now focused on
commercialization of its AI technology. Renovaro Cube believes that it has developed a unique approach to the early detection and diagnosis
of cancer and its recurrence and, in time, other rare diseases through the systematic analysis of data using AI technologies, data mining
procedures and algorithms for health technology.

Renovaro Cube’s technology has been trained on complex heterogeneous cancer
data and appears to find patterns associated with cancer in public and private data resources. With the help of Renovaro Cube’s
algorithms, discovered patterns may be translated into biomarkers that can be used in